Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8 + T cells via trogocytosis

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 744-752

  Gary, Regina ^a   Voelkl, Simon ^a   Palmisano, Ralf ^b   Ullrich, Evelyn ^a   Bosch, Jacobus J ^a   Mackensen, Andreas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROGRAMMED DEATH 1 LIGAND 1;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CELL SELECTION; CELL TRANSFER; CELL TRANSPORT; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; PRIORITY JOURNAL; TROGOCYTOSIS; TUMOR SUPPRESSOR GENE;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD274; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL DEATH; CELL LINE, TUMOR; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; HUMANS; MELANOMA, EXPERIMENTAL; PROTEIN TRANSPORT; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84856009951     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101412     Document Type: Article

References (45)

1. Rechavi, O., I. Goldstein, and Y. Kloog. 2009. Intercellular exchange of proteins: the immune cell habit of sharing. FEBS Lett. 583: 1792-1799.
2. Hudrisier, D., and P. Bongrand. 2002. Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance. FASEB J. 16: 477-486. (Pubitemid 34273231)
3. Bona, C., R. Robineaux, A. Anteunis, C. Heuclin, and A. Astesano. 1973. Transfer of antigen from macrophages to lymphocytes. II. Immunological significance of the transfer of lipopolysaccharide. Immunology 24: 831-840.
4. Huang, J. F., Y. Yang, H. Sepulveda, W. Shi, I. Hwang, P. A. Peterson, M. R. Jackson, J. Sprent, and Z. Cai. 1999. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 286: 952-954.
5. Tsang, J. Y., J. G. Chai, and R. Lechler. 2003. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? Blood 101: 2704-2710. (Pubitemid 36857633)
6. Mostböck, S., M. Catalfamo, Y. Tagaya, J. Schlom, and H. Sabzevari. 2007. Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis. Blood 109: 2488-2495. (Pubitemid 46425893)
7. Sabzevari, H., J. Kantor, A. Jaigirdar, Y. Tagaya, M. Naramura, J. Hodge, J. Bernon, and J. Schlom. 2001. Acquisition of CD80 (B7-1) by T cells. J. Immunol. 166: 2505-2513. (Pubitemid 32173487)
8. Game, D. S., N. J. Rogers, and R. I. Lechler. 2005. Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. Am. J. Transplant. 5: 1614-1625. (Pubitemid 40910443)
9. Tatari-Calderone, Z., R. T. Semnani, T. B. Nutman, J. Schlom, and H. Sabzevari. 2002. Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction. J. Immunol. 169: 6162-6169. (Pubitemid 36903461)
10. Fischer, K., S. Voelkl, J. Heymann, G. K. Przybylski, K. Mondal, M. Laumer, L. Kunz-Schughart, C. A. Schmidt, R. Andreesen, and A. Mackensen. 2005. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4 (-)CD8- double-negative regulatory T cells. Blood 105: 2828-2835. (Pubitemid 40446276)
11. Brezinschek, R. I., N. Oppenheimer-Marks, and P. E. Lipsky. 1999. Activated T cells acquire endothelial cell surface determinants during transendothelial migration. J. Immunol. 162: 1677-1684. (Pubitemid 29307045)
12. Busch, A., T. Quast, S. Keller,W. Kolanus, P. Knolle, P. Altevogt, and A. Limmer. 2008. Transfer of T cell surface molecules to dendritic cells upon CD4+ T cell priming involves two distinct mechanisms. J. Immunol. 181: 3965-3973.
13. Aucher, A., E. Magdeleine, E. Joly, and D. Hudrisier. 2008. Capture of plasma membrane fragments from target cells by trogocytosis requires signaling in T cells but not in B cells. Blood 111: 5621-5628.
14. Quah, B. J., V. P. Barlow, V. McPhun, K. I. Matthaei, M. D. Hulett, and C. R. Parish. 2008. Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer. Proc. Natl. Acad. Sci. USA 105: 4259-4264. (Pubitemid 351754368)
15. Caumartin, J., B. Favier, M. Daouya, C. Guillard, P. Moreau, E. D. Carosella, and J. LeMaoult. 2007. Trogocytosis-based generation of suppressive NK cells. EMBO J. 26: 1423-1433. (Pubitemid 46398697)
16. McCann, F. E., P. Eissmann, B. Onfelt, R. Leung, and D. M. Davis. 2007. The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequences. J. Immunol. 178: 3418-3426. (Pubitemid 46417606)
17. Rafii, A., P. Mirshahi, M. Poupot, A. M. Faussat, A. Simon, E. Ducros, E. Mery, B. Couderc, R. Lis, J. Capdet, et al. 2008. Oncologic trogocytosis of an original stromal cell induces chemoresistance of ovarian tumours. PLoS One 3: e3894.
18. Beum, P. V., D. A. Mack, A. W. Pawluczkowycz, M. A. Lindorfer, and R. P. Taylor. 2008. Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes. J. Immunol. 181: 8120-8132.
19. Riond, J., J. Elhmouzi, D. Hudrisier, and J. E. Gairin. 2007. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells. Scand. J. Immunol. 66: 441-450. (Pubitemid 47394565)
20. Machlenkin, A., R. Uzana, S. Frankenburg, G. Eisenberg, L. Eisenbach, J. Pitcovski, R. Gorodetsky, A. Nissan, T. Peretz, and M. Lotem. 2008. Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs. Cancer Res. 68: 2006-2013. (Pubitemid 351416588)
21. LeMaoult, J., J. Caumartin, M. Daouya, B. Favier, S. Le Rond, A. Gonzalez, and E. D. Carosella. 2007. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 109: 2040-2048. (Pubitemid 46348204)
22. Chemnitz, J. M., R. V. Parry, K. E. Nichols, C. H. June, and J. L. Riley. 2004. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173: 945-954. (Pubitemid 38924267)
23. Carter, L., L. A. Fouser, J. Jussif, L. Fitz, B. Deng, C. R. Wood, M. Collins, T. Honjo, G. J. Freeman, and B. M. Carreno. 2002. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32: 634-643. (Pubitemid 34257540)
24. Shen, T., X. Chen, Y. Chen, Q. Xu, F. Lu, and S. Liu. 2010. Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection. J. Med. Virol. 82: 1152-1159.
25. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687. (Pubitemid 43237609)
26. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203: 2223-2227. (Pubitemid 44498355)
27. Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206: 3015-3029.
28. Amarnath, S., C. M. Costanzo, J. Mariotti, J. L. Ullman, W. G. Telford, V. Kapoor, J. L. Riley, B. L. Levine, C. H. June, T. Fong, et al. 2010. Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol. 8: e1000302.
29. Hino, R., K. Kabashima, Y. Kato, H. Yagi, M. Nakamura, T. Honjo, T. Okazaki, and Y. Tokura. 2010. Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. Cancer 116: 1757-1766.
30. Thompson, R. H., S. M. Kuntz, B. C. Leibovich, H. Dong, C. M. Lohse, W. S. Webster, S. Sengupta, I. Frank, A. S. Parker, H. Zincke, et al. 2006. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res. 66: 3381-3385.
31. Mackensen, A., G. Carcelain, S. Viel, M. C. Raynal, H. Michalaki, F. Triebel, J. Bosq, and T. Hercend. 1994. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest. 93: 1397-1402.
32. Meidenbauer, N., J. Marienhagen, M. Laumer, S. Vogl, J. Heymann, R. Andreesen, and A. Mackensen. 2003. Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J. Immunol. 170: 2161-2169. (Pubitemid 36197440)
33. Salter, R. D., D. N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246. (Pubitemid 15117182)
34. Fischer, K., S. Voelkl, J. Berger, R. Andreesen, T. Pomorski, and A. Mackensen. 2006. Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. Blood 108: 4094-4101. (Pubitemid 44913280)
35. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100: 575-585.
36. Marshansky, V., and M. Futai. 2008. The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr. Opin. Cell Biol. 20: 415-426.
37. Huss, M., and H. Wieczorek. 2009. Inhibitors of V-ATPases: old and new players. J. Exp. Biol. 212: 341-346.
38. Carosella, E. D., P. Moreau, J. Le Maoult, M. Le Discorde, J. Dausset, and N. Rouas-Freiss. 2003. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv. Immunol. 81: 199-252. (Pubitemid 38009044)
39. Davis, D. M. 2007. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat. Rev. Immunol. 7: 238-243.
40. Pham, T., P. Mero, and J. W. Booth. 2011. Dynamics of macrophage trogocytosis of rituximab-coated B cells. PLoS One 6: e14498.
41. Tsushima, F., S. Yao, T. Shin, A. Flies, S. Flies, H. Xu, K. Tamada, D. M. Pardoll, and L. Chen. 2007. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. Blood 110: 180-185. (Pubitemid 47026833)
42. Goldberg, M. V., C. H. Maris, E. L. Hipkiss, A. S. Flies, L. Zhen, R. M. Tuder, J. F. Grosso, T. J. Harris, D. Getnet, K. A. Whartenby, et al. 2007. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood 110: 186-192. (Pubitemid 47026834)
43. Parish, I. A., and S. M. Kaech. 2009. Diversity in CD8(+) T cell differentiation. Curr. Opin. Immunol. 21: 291-297.
44. Hudrisier, D., A. Aucher, A. L. Puaux, C. Bordier, and E. Joly. 2007. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells. J. Immunol. 178: 3637-3647. (Pubitemid 46417631)
45. He, Y. F., X. H. Wang, G. M. Zhang, H. T. Chen, H. Zhang, and Z. H. Feng. 2005. Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy. Cancer Immunol. Immunother. 54: 891-897. (Pubitemid 40991331)